Clinical Trial Update: The Effects of Methylphenidate on Symptomatology in Individuals With Borderline Personality Disorder [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 clinical trial is evaluating the effects of methylphenidate on symptoms in individuals with Borderline Personality Disorder, sponsored by Tanta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Borderline Personality Disorder

Drugs mentioned

• Methylphenidate (Methylphenidate)

Snippet

Sponsor: Tanta University | Conditions: Borderline Personality Disorder | EARLY_Phase 1 | Status: NOT_YET_RECRUITING